News for Lupin Limited (LUPIN.BO)

India-UK FTA boosts leather, textile, and pharma stocks on D-Street; analysts expect major export sectors to benefit as bilateral trade set to double by 2030.

Lupin receives USFDA approval for generic diabetes medications, including Liraglutide Injection and Glucagon for Injection.

The Nifty Pharma index was trading 0.27 per cent up at 22655.9.

The Nifty Pharma index closed 0.32 per cent down at 22593.9.

Lupin, an Indian drug firm, has introduced a generic eye medication in the US. This medication, Loteprednol Etabonate Ophthalmic Suspension, treats eye inflammation and pain. It is a bioequivalent to Bausch & Lomb's Lotemax. The drug addresses post-surgery inflammation and allergic conjunctivitis. The US market for this medication has annual sales of USD 55 million.

Indian stocks may find relief from recent losses, with focus on HCL Technologies and potential regulatory changes.

The Nifty Pharma index was trading 1.05 per cent down at 21975.45.

India Business News: NEW DELHI: In his latest salvo against US trading partners, US President Donald Trump threatened aggressive tariffs on drug imports, raising fresh con.

The Nifty Pharma index closed 0.89 per cent down at 22165.9.

Equity benchmark indices traded flat on Tuesday as investors appeared to have embraced “wait and watch” approach, awaiting clarity in India-US trade deal developments.

The Nifty Pharma index was trading 0.83 per cent down at 22178.45.

Adani Enterprises announces Rs 500 crore NCD issue; Tata Steel faces demand notice; IAF to receive Tejas jets by 2026.

The Nifty Pharma index closed 0.42 per cent up at 22204.25.

The Nifty Pharma index was trading 0.02 per cent down at 22037.75.

See important announcements by SJVN, Grasim Industries, Asian Paints, Paras Defence, Tata Steel, Lupin, Coromandel International, NACL Industries, Zaggle Prepaid, AstraZeneca, Jtekt India, Ceigall, Nazara Tech, JSW Energy, Megasoft

The Nifty Pharma index closed 0.01 per cent up at 22041.25.

India Business News: Pharmaceutical stocks in India fell sharply following US President Donald Trump’s announcement of potential tariffs on the sector. Key companies like Granules India and Lupin faced significant losses as concerns over revenue impact surface.

Indian benchmark indices closed lower on Tuesday, dragged down by financial and oil & gas stocks, as investors turned cautious and booked profits after the previous sessions sharp rally, amid rising geopolitical tensions between Israel and Iran.

Benchmark indices fall as investors book profits amid geopolitical tensions; IT and defence stocks show resilience, others decline.